Boro Drupolitch

Boro Drupolitch is the Executive Director of Kering Cross, an American organization specializing in T-cell therapies for cancer treatment. He emphasizes the importance of international collaboration in healthcare and recently expressed enthusiasm for partnerships aimed at sustainable advancements in medical care during the Abu Dhabi Global Health Week.